Ocugen, Inc.
Ocugen, Inc. (OCGN) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · OCGN · as of Sep 30, 2025
Ownership Breakdown
104
Institutional Holders
▼ 5 vs Q2
$75.37M
Total Inst. Value
▲ $25.27M vs Q2
338.52M
Shares Outstanding
freeFloat 93.60%
46.49M
13F Shares Held
▼ 5.16M vs Q2
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
OCGN largest shareholders · institutional ownership
Q3 2025 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
VANGUARD GROUP INC biological products, (no diagnostic substances) | 15.22M | 5.21% | 5.21% | $24.81B | Nov 7, 2025 | ▲ 450.9K |
MILLENNIUM MANAGEMENT LLC biological products, (no diagnostic substances) | 4.16M | 1.43% | 1.43% | $6.78B | Nov 14, 2025 | ▼ 896.8K |
GMT CAPITAL CORP biological products, (no diagnostic substances) | 4.15M | 1.42% | 1.42% | $6.77B | Nov 14, 2025 | — held |
BLACKROCK, INC. biological products, (no diagnostic substances) | 4.05M | 1.39% | 1.39% | $6.61B | Nov 12, 2025 | ▼ 1.54M |
GEODE CAPITAL MANAGEMENT, LLC biological products, (no diagnostic substances) | 3.68M | 1.26% | 1.26% | $6.00B | Nov 12, 2025 | ▲ 189.4K |
CITADEL ADVISORS LLC biological products, (no diagnostic substances) | 1.57M | 53.70% | 53.70% | $2.56B | Nov 14, 2025 | ▲ 966.2K |
STATE STREET CORP biological products, (no diagnostic substances) | 1.36M | 46.41% | 46.41% | $2.21B | Nov 14, 2025 | ▲ 16.5K |
RINKEY INVESTMENTS biological products, (no diagnostic substances) | 1.11M | 38.10% | 38.10% | $1.81B | Nov 14, 2025 | ▼ 66.3K |
GSA CAPITAL PARTNERS LLP biological products, (no diagnostic substances) | 1.04M | 35.67% | 35.67% | $1.70B | Nov 7, 2025 | ▼ 687.0K |
UBS GROUP AG biological products, (no diagnostic substances) | 1.02M | 35.09% | 35.09% | $1.67B | Nov 13, 2025 | ▲ 370.5K |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q3 2025 vs prior quarter
Q3 2025
22
Increased
+4.02M shares6
New Positions
first time holders19
Decreased
−7.39M shares0
Sold Out
fully exitedNet shares change (top 50)
3.37M
+4.02M / −7.39M
Net new holders
+9
6 new / 0 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
OCGN insider trading · insider activity
Source: SEC Form 4
3
Buy transactions
3
Sell transactions
1.00
Buy/Sell ratio
$0M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
Musunuri Shankar Chief Executive Officer | Jan 2, 2026 | Award | 3,123,201 | — | — | 4.96M | Form 4 ↗ |
Musunuri Shankar Chief Executive Officer | Jan 2, 2026 | Award | 3,123,201 | $1.38 | $4.31M | 3.12M | Form 4 ↗ |
Ramachandran Ramesh Chief Accounting Officer | Jan 2, 2026 | Award | 310,950 | $1.38 | $429.1K | 310.9K | Form 4 ↗ |
Ramachandran Ramesh Chief Accounting Officer | Jan 2, 2026 | Award | 207,300 | — | — | 209.1K | Form 4 ↗ |
Chandrasekhar Satishchandran director | Jun 5, 2025 | Award | 151,316 | $0.95 | $143.8K | 151.3K | Form 4 ↗ |
Coleman Blaise director | Jun 5, 2025 | Award | 151,316 | $0.95 | $143.8K | 151.3K | Form 4 ↗ |
Castillo Kirsten director | Jun 5, 2025 | Award | 151,316 | $0.95 | $143.8K | 151.3K | Form 4 ↗ |
Kompella Uday director | Jun 5, 2025 | Award | 151,316 | $0.95 | $143.8K | 151.3K | Form 4 ↗ |
Zhang Junge director | Jun 5, 2025 | Award | 151,316 | $0.95 | $143.8K | 151.3K | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
Ocugen, Inc. (OCGN) is primarily owned by institutional investors, who hold approximately 13.7% of total shares outstanding. Company insiders own approximately 6.40%, while retail and public investors account for the remaining 79.87%.
The largest institutional shareholder of Ocugen, Inc. is VANGUARD GROUP INC, holding approximately 15.22 million shares — equal to 5.21% of outstanding shares — as of September 30, 2025.
A total of 104 institutional investors currently hold OCGN stock, with a combined institutional value of approximately $75,373,761 as of the most recent 13F filing period.
Frequently asked questions
OCGN ownershipOcugen, Inc. (OCGN) is primarily owned by institutional investors, who hold approximately 13.7% of shares. The largest shareholder is VANGUARD GROUP INC with a 5.21% stake. Company insiders hold 6.40%. Data sourced from SEC Form 13F as of September 30, 2025.